Thyrocare

Thyrocare Reports Strong Q1FY26 Results with 23% YoY Revenue Growth

New Delhi [India], July 31:  Thyrocare Technologies Limited (hereinafter referred to as “THYROCARE” NSE: THYROCARE, BSE: 539871), a leading healthcare diagnostics company, has announced its financial results for the first quarter of FY26, ending June 30, 2025. The company reported a consolidated revenue of ₹193.03 crore for Q1FY26, marking a solid 23 percent growth compared […]

Continue Reading

Thyrocare Q4FY25 Revenue Up 21 Percent YoY to Rs 187.2 Cr; PAT Rises 24 Percent to Rs 21.3 Cr

Navi Mumbai (Maharashtra) [India], April 25: Thyrocare Technologies Limited (hereinafter referred to as “Thyrocare” NSE: THYROCARE, BSE: 539871), a leading healthcare diagnostics company, announces their results for the quarter ended March 31, 2025. For Q4FY25, the company reported revenue from operations of INR 187.2 crore, reflecting a 21% year-over-year (YoY) growth. Normalized EBITDA for the […]

Continue Reading